申请人:Takhi Mohamed
公开号:US20100298384A1
公开(公告)日:2010-11-25
The present invention relates to novel oxazolidinone compounds of formula (I) with antibacterial activity, their pharmaceutically acceptable salts, their stereoisomers, their prodrugs, pharmaceutical compositions comprising the same and to their use as therapeutic agents
本发明涉及具有抗菌活性的新型噁唑烷酮化合物(I)及其药学上可接受的盐、立体异构体、前药、包含其的制药组合物以及将其用作治疗剂的用途。